Memantine 10mgml oral solution sugar free

Country: United Kingdom

Bahasa: Inggeris

Sumber: MHRA (Medicines & Healthcare Products Regulatory Agency)

Bahan aktif:

Memantine hydrochloride

Boleh didapati daripada:

Rosemont Pharmaceuticals Ltd

Kod ATC:

N06DX01

INN (Nama Antarabangsa):

Memantine hydrochloride

Dos:

10mg/1ml

Borang farmaseutikal:

Oral solution

Laluan pentadbiran:

Oral

Kelas:

No Controlled Drug Status

Jenis preskripsi:

Valid as a prescribable product

Ringkasan produk:

BNF: 04110000

Risalah maklumat

READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
n
Keep this leaflet. You may need to read it again.
n
If you have any further questions, ask your doctor or pharmacist.
n
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same
as yours.
n
If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What Memantine Oral Solution is and what it is used for
2. What you need to know before you take Memantine Oral Solution
3. How to take Memantine Oral Solution
4. Possible side effects
5. How to store Memantine Oral Solution
6. Contents of the pack and other information
1. WHAT MEMANTINE ORAL SOLUTION IS AND WHAT IT IS USED FOR
HOW DOES MEMANTINE ORAL SOLUTION WORK
Memantine Oral Solution belongs to a group of medicines known as
anti-dementia
medicines.
Memory loss in Alzheimer’s disease is due to a disturbance of
message signals in the brain.
n
The brain contains so-called N-methyl-D-aspartate (NMDA)-receptors
that are involved in
transmitting nerve signals important in learning and memory.
n
Memantine belongs to a group of medicines called NMDA-receptor
antagonists.
Memantine acts on these NMDA-receptors improving the transmission of
nerve signals
and the memory.
WHAT IS MEMANTINE ORAL SOLUTION USED FOR
Memantine Oral Solution is used for the treatment of patients with
moderate to severe
Alzheimer’s disease.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MEMANTINE ORAL SOLUTION
DO NOT TAKE MEMANTINE ORAL SOLUTION
n
if you are allergic (hypersensitive) to the memantine hydrochloride or
any of the other
ingredients of Memantine Oral Solution (see section 6).
WARNINGS AND PRECAUTIONS
Talk to your doctor before taking Memantine Oral Solution:
n
if you have a history of epileptic seizures
n
if you have recently experienced a myocardial infarction (heart
att

Ciri produk

OBJECT 1
MEMANTINE HYDROCHLORIDE 10MG/ML ORAL
SOLUTION
Summary of Product Characteristics Updated 20-Jun-2016 | Rosemont
Pharmaceuticals Limited
1. Name of the medicinal product
Memantine Hydrochloride 10mg/ml Oral Solution
2. Qualitative and quantitative composition
Each millilitre (ml) of solution contains 10mg Memantine Hydrochloride
which is equivalent to 8.32 mg
memantine
Excipients:
Each millilitre of solution contains 100 mg sorbitol (E420) and 0.5 mg
potassium, see section 4.4
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Oral Solution
A clear colourless solution.
4. Clinical particulars
4.1 Therapeutic indications
Treatment of patients with moderate to severe Alzheimer's disease.
4.2 Posology and method of administration
Treatment should be initiated and supervised by a physician
experienced in the diagnosis and treatment of
Alzheimer's dementia. Therapy should only be started if a caregiver is
available who will regularly
monitor the intake of the medicinal product by the patient. Diagnosis
should be made according to current
guidelines. The tolerance and dosing of memantine should be reassessed
on a regular basis, preferably
within three months after start of treatment. Thereafter, the clinical
benefit of memantine and the patient's
tolerance of treatment should be reassessed on a regular basis
according to current clinical guidelines.
Maintenance treatment can be continued for as long as a therapeutic
benefit is favourable and the patient
tolerates treatment with memantine. Discontinuation of memantine
should be considered when evidence
of a therapeutic effect is no longer present or if the patient does
not tolerate treatment.
Memantine Oral Solution should be taken once daily at the same time
each day. The solution can be taken
with or without food.
The solution is withdrawn from the bottle with the oral syringe and
can be swallowed directly from the
oral syringe. Alternatively, it can be dosed onto a spoon or into a
glass of water using the syringe.
_Adults:_
Dose titration